ARCHIVES

Clinical Trials: “Master Protocol” To Rely On Biomarkers In Testing Multiple Lung Cancer Agents

This article is from The Cancer Letter archive.

Vol. 39 No. 43 | November 15, 2013

Download PDF Visit The Full Archive

Related Articles

Lymphoseek Label Updated To Include Head and Neck SCC

June 27, 2014

ASCO Urges NCI To Spell Out Metrics of Success Beyond Cutting Groups to Arbitrary Number

June 17, 2011

On More Victory For Sol Garb: FDA Approves THC

June 14, 1985

Gramm-Rudman Cut Facing NCI Could Take $85 Million

October 20, 1989

In Brief: Gritz Heads New Dept. At M.D. Anderson; NCI Grants Manager Leo Buscher honored

July 16, 1993

Tobacco Control: NCI Report Counters View Of Cigar Smoking As Safer Alternative

April 17, 1998